Collaboration aims to improve accessibility and adoption of multi-cancer early detection solutions through a broader practitioner network ...
Investment manager Michael Lamprecht highlights structural funding gaps, regulatory fragmentation, and the need for commercially viable antimicrobial resistance strategies ...
The launch of pTau217 marks a significant step in providing a simple, blood-based tool to diagnose Alzheimer's much earlier in the patient journey...
The FDA 510(k) clearance advances Biozen’s BP1000, a handheld fingertip device designed to deliver clinically validated spot blood pressure measurements without an arm cuff or per-user calibration. ...
The event highlighted healthcare AI’s shift from experimentation to real-world deployment, with discussions on accountability, governance, workforce readiness and exhibitor solutions including Heidi and AITRICS-VC....
The NMPA designation advances NHWD-870 HCI, an oral BET inhibitor for advanced thoracic NUT carcinoma, following Phase II data showing anti-tumour activity and survival benefit in a rare, aggressive cancer with limited treatment options. ...
The Tokyo office will support Japanese biopharmaceutical companies across the product lifecycle, combining market access, medical, marketing and strategic consulting capabilities under the leadership of Junji Yokokawa. ...
India Sebia, in collaboration with CAHO Diagnostic Division, is proud to announce the launch of the Autoimmunity Masterclass Series—a six-part academic webinar initiative aimed at advancing the understanding, early diagnosis, and clinical management of autoimmune diseases....
Jointly developed by SGH, SingHealth and MOHT, LEA-Net uses patient data to identify individuals at higher risk of lower extremity amputation three to five years before foot ulcers and infections develop. ...
NuvioDx will support the deployment of Nanox.ARC multi-source digital tomosynthesis systems across clinical sites in various states...
